Brickell Invested Capital vs Enterprise Value Analysis

BBI Stock

USD 0.90 0.01 1.10%

Brickell Biotech financial indicator trend analysis is way more than just evaluating Brickell Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Brickell Biotech is a good investment. Please check the relationship between Brickell Biotech Invested Capital and its Enterprise Value accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.

Invested Capital vs Enterprise Value

Invested Capital vs Enterprise Value Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Brickell Biotech Invested Capital account and Enterprise Value. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Brickell Biotech's Invested Capital and Enterprise Value is 0.48. Overlapping area represents the amount of variation of Invested Capital that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Brickell Biotech, assuming nothing else is changed. The correlation between historical values of Brickell Biotech's Invested Capital and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Invested Capital of Brickell Biotech are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Invested Capital i.e., Brickell Biotech's Invested Capital and Enterprise Value go up and down completely randomly.

Correlation Coefficient

0.48

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Brickell Biotech. There are two different methods for calculating Brickell Biotech invested capital: operating approach and financing approach. Understanding Brickell Biotech invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Brickell Biotech theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Brickell Biotech debt, but would also pocket its cash. Enterprise Value is more accurate representation of Brickell Biotech value than its market capitalization because it takes into account all of Brickell Biotech existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Most indicators from Brickell Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.The current Selling General Administrative is estimated to decrease to about 10.6 M. The current Issuance Of Capital Stock is estimated to decrease to about 22.7 M

	2023	2024 (projected)
Total Operating Expenses	46.7M	29.0M
Cost Of Revenue	23.2M	24.4M

Total Operating Expenses Cost Of Revenue

Brickell Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Assets	Common Stock Total Equity	Common Stock	Current Deferred Revenue
Total Assets		0.82	0.25	0.33	0.99	0.68	-0.58	-0.81	-0.43	0.58	0.76	0.37	0.92	0.52	-0.42	0.19	0.85	0.42	0.68	0.91	0.65	0.75	-0.4	0.46	0.01	0.15
Short Long Term Debt Total	0.82		-0.04	0.11	0.83	0.63	-0.13	-0.94	-0.68	0.13	0.78	0.65	0.64	0.69	-0.73	-0.05	0.92	0.17	0.63	0.65	0.88	0.66	-0.18	0.31	-0.31	0.01
Other Current Liab	0.25	-0.04		0.47	0.18	0.36	-0.47	0.07	0.24	0.41	0.27	-0.5	0.17	0.19	-0.03	-0.15	-0.05	0.54	0.36	0.23	-0.36	0.41	-0.33	0.31	0.16	0.07
Total Current Liabilities	0.33	0.11	0.47		0.2	-0.13	-0.08	-0.21	0.41	0.05	-0.02	0.23	0.28	0.31	-0.1	-0.39	0.21	0.98	-0.13	0.4	-0.01	-0.08	-0.13	-0.31	-0.27	0.83
Total Stockholder Equity	0.99	0.83	0.18	0.2		0.71	-0.58	-0.82	-0.5	0.59	0.78	0.35	0.92	0.49	-0.41	0.26	0.86	0.3	0.71	0.9	0.68	0.78	-0.4	0.52	0.06	0.04
Property Plant And Equipment Net	0.68	0.63	0.36	-0.13	0.71		-0.59	-0.44	-0.56	0.56	0.96	0.04	0.53	0.28	-0.48	0.32	0.46	0.02	1.0	0.5	0.38	0.99	-0.11	0.59	0.05	-0.35
Net Debt	-0.58	-0.13	-0.47	-0.08	-0.58	-0.59		0.13	0.05	-0.98	-0.48	0.34	-0.63	0.06	-0.19	-0.54	-0.21	-0.21	-0.58	-0.58	0.06	-0.63	0.43	-0.69	-0.56	0.08
Retained Earnings	-0.81	-0.94	0.07	-0.21	-0.82	-0.44	0.13		0.5	-0.13	-0.62	-0.62	-0.69	-0.72	0.53	-0.02	-0.98	-0.24	-0.44	-0.71	-0.88	-0.5	0.41	-0.3	0.17	-0.09
Accounts Payable	-0.43	-0.68	0.24	0.41	-0.5	-0.56	0.05	0.5		-0.07	-0.62	-0.46	-0.29	-0.37	0.63	0.04	-0.48	0.36	-0.56	-0.24	-0.63	-0.52	-0.19	-0.27	0.3	0.28
Cash	0.58	0.13	0.41	0.05	0.59	0.56	-0.98	-0.13	-0.07		0.47	-0.31	0.61	-0.09	0.2	0.58	0.21	0.16	0.56	0.54	-0.01	0.61	-0.45	0.69	0.56	-0.1
Non Current Assets Total	0.76	0.78	0.27	-0.02	0.78	0.96	-0.48	-0.62	-0.62	0.47		0.23	0.58	0.41	-0.58	0.26	0.62	0.11	0.96	0.56	0.57	0.95	-0.14	0.5	-0.07	-0.23
Non Currrent Assets Other	0.37	0.65	-0.5	0.23	0.35	0.04	0.34	-0.62	-0.46	-0.31	0.23		0.24	0.39	-0.63	-0.28	0.56	0.19	0.04	0.27	0.76	0.01	0.29	-0.34	-0.65	0.39
Cash And Short Term Investments	0.92	0.64	0.17	0.28	0.92	0.53	-0.63	-0.69	-0.29	0.61	0.58	0.24		0.32	-0.15	0.36	0.78	0.4	0.53	0.98	0.55	0.62	-0.48	0.46	0.22	0.12
Net Receivables	0.52	0.69	0.19	0.31	0.49	0.28	0.06	-0.72	-0.37	-0.09	0.41	0.39	0.32		-0.44	-0.39	0.7	0.31	0.28	0.44	0.44	0.3	-0.22	0.07	-0.25	0.27
Common Stock Shares Outstanding	-0.42	-0.73	-0.03	-0.1	-0.41	-0.48	-0.19	0.53	0.63	0.2	-0.58	-0.63	-0.15	-0.44		0.47	-0.44	-0.11	-0.49	-0.17	-0.64	-0.45	-0.27	0.05	0.76	0.01
Non Current Liabilities Total	0.19	-0.05	-0.15	-0.39	0.26	0.32	-0.54	-0.02	0.04	0.58	0.26	-0.28	0.36	-0.39	0.47		0.1	-0.29	0.32	0.25	0.09	0.34	-0.42	0.44	0.65	-0.46
Other Stockholder Equity	0.85	0.92	-0.05	0.21	0.86	0.46	-0.21	-0.98	-0.48	0.21	0.62	0.56	0.78	0.7	-0.44	0.1		0.27	0.46	0.8	0.84	0.53	-0.45	0.35	-0.06	0.09
Total Liab	0.42	0.17	0.54	0.98	0.3	0.02	-0.21	-0.24	0.36	0.16	0.11	0.19	0.4	0.31	-0.11	-0.29	0.27		0.02	0.52	0.01	0.07	-0.16	-0.2	-0.19	0.76
Property Plant And Equipment Gross	0.68	0.63	0.36	-0.13	0.71	1.0	-0.58	-0.44	-0.56	0.56	0.96	0.04	0.53	0.28	-0.49	0.32	0.46	0.02		0.49	0.39	0.99	-0.11	0.59	0.05	-0.35
Total Current Assets	0.91	0.65	0.23	0.4	0.9	0.5	-0.58	-0.71	-0.24	0.54	0.56	0.27	0.98	0.44	-0.17	0.25	0.8	0.52	0.49		0.52	0.58	-0.47	0.4	0.18	0.23
Short Term Debt	0.65	0.88	-0.36	-0.01	0.68	0.38	0.06	-0.88	-0.63	-0.01	0.57	0.76	0.55	0.44	-0.64	0.09	0.84	0.01	0.39	0.52		0.41	-0.21	0.1	-0.38	-0.08
Intangible Assets	0.75	0.66	0.41	-0.08	0.78	0.99	-0.63	-0.5	-0.52	0.61	0.95	0.01	0.62	0.3	-0.45	0.34	0.53	0.07	0.99	0.58	0.41		-0.23	0.66	0.12	-0.34
Other Current Assets	-0.4	-0.18	-0.33	-0.13	-0.4	-0.11	0.43	0.41	-0.19	-0.45	-0.14	0.29	-0.48	-0.22	-0.27	-0.42	-0.45	-0.16	-0.11	-0.47	-0.21	-0.23		-0.46	-0.47	0.24
Common Stock Total Equity	0.46	0.31	0.31	-0.31	0.52	0.59	-0.69	-0.3	-0.27	0.69	0.5	-0.34	0.46	0.07	0.05	0.44	0.35	-0.2	0.59	0.4	0.1	0.66	-0.46		0.67	-0.46
Common Stock	0.01	-0.31	0.16	-0.27	0.06	0.05	-0.56	0.17	0.3	0.56	-0.07	-0.65	0.22	-0.25	0.76	0.65	-0.06	-0.19	0.05	0.18	-0.38	0.12	-0.47	0.67		-0.28
Current Deferred Revenue	0.15	0.01	0.07	0.83	0.04	-0.35	0.08	-0.09	0.28	-0.1	-0.23	0.39	0.12	0.27	0.01	-0.46	0.09	0.76	-0.35	0.23	-0.08	-0.34	0.24	-0.46	-0.28

Click cells to compare fundamentals

Brickell Biotech Account Relationship Matchups

Brickell Biotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	52.3M	18.1M	33.6M	29.7M	34.2M	32.5M
Other Current Liab	(1.5M)	6.4M	5.4M	3.1M	3.6M	3.8M
Total Current Liabilities	3.6M	10.5M	6.4M	4.8M	5.5M	6.8M
Total Stockholder Equity	48.8M	7.6M	27.1M	24.9M	28.6M	27.2M
Property Plant And Equipment Net	100K	175K	104K	117K	134.6K	127.8K
Net Debt	(7.2M)	(7.1M)	(29.6M)	(26.8M)	(24.1M)	(25.3M)
Retained Earnings	(442.1M)	(85.0M)	(105.9M)	(145.4M)	(130.8M)	(137.4M)
Accounts Payable	412K	2.2M	568K	1.6M	1.4M	1.6M
Cash	11.9M	7.2M	30.1M	26.9M	30.9M	21.3M
Non Current Assets Total	3.1M	175K	104K	117K	134.6K	127.8K
Cash And Short Term Investments	48.1M	11.7M	30.1M	26.9M	30.9M	51.3M
Common Stock Shares Outstanding	69.3K	67.2K	544.8K	1.8M	2.1M	2.2M
Liabilities And Stockholders Equity	52.3M	18.1M	33.6M	29.7M	34.2M	32.5M
Non Current Liabilities Total	1.7M	73K	146K	1.7M	1.5M	1.6M
Other Stockholder Equity	490.3M	74.4M	132.5M	169.1M	194.4M	255.6M
Total Liab	3.6M	10.6M	6.5M	4.8M	5.5M	8.9M
Property Plant And Equipment Gross	606K	100K	175K	104K	119.6K	113.6K
Total Current Assets	49.2M	18.0M	33.5M	29.6M	34.0M	62.7M
Short Term Debt	4.6M	78K	365K	69K	79.4K	75.4K
Other Current Assets	1.1M	6.2M	3.4M	2.7M	2.4M	2.3M
Net Tangible Assets	48.8M	7.6M	27.1M	24.9M	22.4M	36.3M
Retained Earnings Total Equity	(426.7M)	(442.1M)	(85.0M)	(105.9M)	(121.8M)	(127.9M)
Capital Surpluse	490.0M	490.3M	92.5M	132.5M	119.2M	113.3M
Property Plant Equipment	100K	16K	30K	117K	105.3K	100.0K
Net Invested Capital	48.8M	7.6M	27.6M	24.9M	22.4M	27.6M
Net Working Capital	45.6M	7.5M	27.2M	24.8M	22.3M	26.3M

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Brickell Stock

0.83	OPT	Opthea	Pair Corr
0.82	ANIP	ANI Pharmaceuticals Financial Report 13th of May 2024	Pair Corr
0.81	PAHC	Phibro Animal Health Financial Report 1st of May 2024	Pair Corr
0.76	CNTA	Centessa Pharmaceuticals Downward Rally	Pair Corr
0.73	AVTE	Aerovate Therapeutics Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.

The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Brickell Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brickell Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brickell Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brickell Biotech Stock:

How To Invest In Brickell

Details

Is Brickell Stock a good investment?

Details

What is Brickell Biotech's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.

Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.

	CEOs Directory Screen CEOs from public companies around the world
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.42)

Revenue Per Share

1.94

Quarterly Revenue Growth

27.576

Return On Assets

(0.80)

Return On Equity

(1.57)

The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Brickell Invested Capital vs Enterprise Value Analysis

Invested Capital vs Enterprise Value

Invested Capital vs Enterprise Value Correlation Analysis

Correlation Coefficient

Invested Capital

Enterprise Value

Brickell Biotech fundamental ratios Correlations

Brickell Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Brickell Biotech fundamental ratios Accounts

Pair Trading with Brickell Biotech

Moving against Brickell Stock

Complementary Tools for Brickell Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Intangible Assets	+ 0.99	Property Plant And Equipment Net
Intangible Assets	+ 0.99	Property Plant And Equipment Gross
Total Liab	+ 0.98	Total Current Liabilities
Total Current Assets	+ 0.98	Cash And Short Term Investments

Other Stockholder Equity	- 0.98	Retained Earnings
Cash	- 0.98	Net Debt
Retained Earnings	- 0.94	Short Long Term Debt Total
Short Term Debt	- 0.88	Retained Earnings
Retained Earnings	- 0.82	Total Stockholder Equity
Retained Earnings	- 0.81	Total Assets